Skip to main content
Clinical Trials/NL-OMON44121
NL-OMON44121
Completed
Not Applicable

Biological variation of cardiac biomarkers in aortic valve stenosis - Biological variation of cardiac biomarkers in aortic valve stenosis

Medisch Universitair Ziekenhuis Maastricht0 sites25 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic stenosis
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
25
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 16, 2017
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • Individuals (aged \* 18 years) with clinically stable moderate aortic valve stenosis, defined by serial Doppler echocardiographic measurements of maximum transvalvular velocity (Vmax), mean pressure gradient (PGmean), and Aortic Valve Area (AVA) and a preserved ejection fraction (EF), will be recruited to participate in this study. Only subjects who are able to provide informed consent will be included.

Exclusion Criteria

  • Subjects with severe aortic valve stenosis
  • Subjects with clinically progressive aortic valve stenosis
  • Subjects with documented atrial fibrillation in the last year. (subjects are allowed to have a history of atrial fibrillation)
  • Subjects with acute myocardial infarction in the last 6 months
  • Subjects with hospitalisation for heart failure in the last 6 months
  • Subjects with pulmonary embolism in the last 6 months
  • Subjects with chronic kidney disease (CKD)

Outcomes

Primary Outcomes

Not specified

Similar Trials